好评率
100%
  • Wang J; Zhang Z; Zhuo Y, et al., Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy. Acta Pharmaceutica Sinica B 2024.
    IF: 14.5
    Year: 2024 Journal: Acta Pharm Sin B
    PubMed: 39234613
  • Zeng X; Fan L; Qin Q, et al., Exogenous PD-L1 binds to PD-1 to alleviate and prevent autism-like behaviors in maternal immune activation-induced male offspring mice. Brain Behav Immun 2024, 122, 527-546.
    IF: 8.8
    Year: 2024 Journal: Brain Behav Immun
    PubMed: 39182588
  • Ning B; Liu Y; Ouyang B, et al., Low-temperature photothermal irradiation triggers alkyl radicals burst for potentiating cancer immunotherapy. J Colloid Interface Sci 2022, 614, 436-450.
    IF: 8.128
    Year: 2022 Journal: J Colloid Interf Sci
    PubMed: 35108635
  • Sun H; Song X; Li C, et al., Humanized disulfide-stabilized diabody against fibroblast growth factor-2 inhibits PD-L1 expression and epithelial-mesenchymal transition in hepatoma cells through STAT3. IUBMB Life 2023, 75 (11), 957-968.
    IF: 4.6
    Year: 2023 Journal: IUBMB Life
    PubMed: 37489553
  • Li S; Feng S; Chen Y, et al., Ciclopirox platinum(IV) conjugates suppress tumors by promoting mitophagy and provoking immune responses. J Inorg Biochem 2024, 260, 112696.
    IF: 3.8
    Year: 2024 Journal: J Inorg Biochem
    PubMed: 39142055
  • Liu J; Li W; Lu R, et al., Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma. Oncol Res 2024, 32 (4), 717-726.
    IF: 3.1
    Year: 2024 Journal: Oncol Res
    PubMed: 38560576
0
产品咨询微信

服务热线

400-602-0407

APP下载
生物狗小程序